Neoplasm Metastasis clinical trials at UC Cancer

1 research study open to eligible people

Study of PF-07265807 in Participants With Metastatic Solid Tumors.
open to eligible people ages 18 years and up
A First-in-Human Pharmacokinetic, Safety, and Tolerability Study of PF-07265807 as Monotherapy and in Combination in Participants with Advanced or Metastatic Solid Tumors
at UCSF

Last updated: June 20, 2022